RxDoctor Payments Data

Tito Velasquez

Physician Assistant · Fort Lauderdale, FLNPI 1013551266

Payments from drug & device makers

$1,976in general payments, 2019–2025

Across 43 payments — averaging $45.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$642
  • Johnson & Johnson$478
  • Janssen Scientific Affairs, LLC$235
  • Madrigal Pharmaceuticals$148
  • Lucid Diagnostics Inc.$117
  • Amgen$88
  • plus $269 from 9 others

What the payments were for

  • Food & beverage$1,976100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,976 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$4,266
Medicare patients
52
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpclusaSofosbuvir/Velpatasvir11$247,695
Humira(Cf) PenAdalimumab28$241,985
XifaxanRifaximin62$202,226
RinvoqUpadacitinib21$161,502
RezdiffraResmetirom16$83,270
LinzessLinaclotide52$49,882
CreonLipase/Protease/Amylase27$35,348
MovantikNaloxegol Oxalate12$13,969
SutabSod Sulf/Pot Chloride/Mag Sulf40$6,619
Esomeprazole Magnesium40$2,124
CholestyramineCholestyramine (With Sugar)23$1,988
Ondansetron OdtOndansetron88$1,925
Pantoprazole Sodium154$1,696
Omeprazole106$1,598
Desipramine Hcl55$1,338

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Linzess, Creon$642$246,731100 claims
Madrigal PharmaceuticalsRezdiffra$148$83,27016 claims
Braintree Laboratories, Inc.Sutab$15$6,61940 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Fort Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →